Search Results - "Schellong, S."

Isolated distal deep vein thrombosis: what we know and what we are doing by PALARETI, G., SCHELLONG, S.

“…Thromboses that are restricted to the infra‐popliteal deep veins of the lower limbs (isolated distal deep vein thrombosis, IDDVT) are frequently diagnosed in…”
Get full text

D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial by Cohen, A. T., Spiro, T.E., Spyropoulos, A. C., DeSanctis, Y. H., Homering, M., Büller, H. R., Haskell, L., Hu, D., Hull, R., Mebazaa, A., Merli, G., Schellong, S., Tapson, V. F., Burton, P.

“…Summary Background D‐dimer concentrations have not been evaluated extensively as a predictor of increased venous thromboembolism (VTE) risk in acutely ill,…”
Get full text

Isolated distal deep vein thrombosis: what we know and what we are doing by PALARETI, G., SCHELLONG, S.

Get full text

Hospitalization for vitamin‐K‐antagonist‐related bleeding: treatment patterns and outcome by Halbritter, K., Beyer‐Westendorf, J., Nowotny, J., Pannach, S., Kuhlisch, E., Schellong, S. M.

“…Summary Background Bleeding complications are common side effects of vitamin‐K antagonist (VKA) therapy. Data on the in‐hospital management and outcomes of…”
Get full text

Distal DVT: worth diagnosing? Yes by SCHELLONG, S. M.

“…Much of the argument for or against diagnosis of distal deep vain thrombosis (DVT) depends on the extra effort that has to be spent on it. This review presents…”
Get full text

Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests by GREINACHER, A., ITTERMANN, T., BAGEMÜHL, J., ALTHAUS, K., FÜRLL, B., SELLENG, S., LUBENOW, N., SCHELLONG, S., SHEPPARD, J. I., WARKENTIN, T.E.

“…Background: Laboratory confirmation of heparin‐induced thrombocytopenia (HIT) is based on detection of heparin‐dependent platelet‐activating antibodies…”
Get full text

Diagnosis of recurrent deep vein thrombosis by Schellong, S M

“…Deep vein thrombosis is a chronic disease with a continuing risk of recurrence. In a patient with recurrence long term prognosis and treatment are…”
Get more information

Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes by Zöllner, H., Jouni, R., Panzer, S., Khadour, A., Janzen, L., Wesche, J., Berg, M., Schellong, S., Heinken, A., Greinacher, A., Bakchoul, T.

“…Essentials Protamine (PRT) is used to stabilize insulin in neutral protamine Hagedorn (NPH) insulin. The interaction between NPH‐insulin, anti‐PRT/heparin…”
Get full text

Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study by GIBSON, N. S., SCHELLONG, S. M., KHEIR, D. Y. El, BEYER‐WESTENDORF, J., GALLUS, A. S., MCRAE, S., SCHUTGENS, R. E. G., PIOVELLA, F., GERDES, V. E. A., BULLER, H. R.

“…Background: It remains unclear whether a single complete ultrasound examination, which detects calf vein thrombosis, is as safe as a baseline rapid ultrasound…”
Get full text

Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study by SCHELLONG, S. M., BEYER, J., KAKKAR, A. K., HALBRITTER, K., ERIKSSON, B. I., TURPIE, A. G. G., MISSELWITZ, F., KÄLEBO, P.

“…Background: Venography is currently used to assess the incidence of deep vein thrombosis (DVT) in dose‐finding and confirmatory trials of new antithrombotic…”
Get full text

A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study by RIESS, H., HAAS, S., TEBBE, U., GERLACH, H.‐E., ABLETSHAUSER, C., SIEDER, C., ROSSOL, S., PFEIFFER, B., SCHELLONG, S. M.

“…Background: In medically ill patients, no contemporary double‐blind head‐to‐head evaluation of low molecular weight heparin vs. unfractionated heparin (UFH)…”
Get full text

Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery by BEYER, J., WESSELA, S., HAKENBERG, O. W., KUHLISCH, E., HALBRITTER, K., FROEHNER, M., WIRTH, M. P., SCHELLONG, S. M.

“…Background: Venous thromboembolism (VTE) is the most common non‐surgical complication after major pelvic surgery. Little is known about the risk factors or the…”
Get full text

Dabigatran therapy--perioperative management and interpretation of coagulation tests by Spannagl, M, Bauersachs, R, Debus, E S, Gawaz, M, Gerlach, H, Haas, S, Hach-Wunderle, V, Lindhoff-Last, E, Riess, H, Schellong, S, Schinzel, H, Bode, C

“…Dabigatran, an oral, reversible direct factor IIa inhibitor, is approved in Europe for stroke prevention in atrial fibrillation and for the prevention of…”
Get more information

Central adjudication of venous ultrasound in VTE screening trials: reasons for failure by BEYER‐WESTENDORF, J., HALBRITTER, K., PLATZBECKER, H., DAMME, U., NEUGEBAUER, B., KUHLISCH, E., SCHELLONG, S.

“…Background: The accuracy of screening ultrasound for venous thrombosis in asymptomatic patients is still a matter of debate. The VENUS study evaluated the…”
Get full text

Complete Ulcer Healing as Primary Endpoint in Studies on Critical Limb Ischemia? A Critical Reappraisal by Hoffmann, U, Schulte, K.-L, Heidrich, H, Rieger, H, Schellong, S

“…Objectives Although complete ulcer healing is the mandatory primary efficacy criterion in current European guidelines for drug trials in critical limb ischemia…”
Get full text

Re-evaluation of elastic compression stockings for thrombosis prevention by Schellong, S

Get more information

Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: An analysis of the CERTIFY study by Schellong, S.M, Gerlach, H.-E, Tebbe, U, Haas, S, Melzer, N, Abletshauser, C, Sieder, C, Bramlage, P, Riess, H, Bauersachs, R

“…Abstract Introduction There is an exponential rise of thromboembolic risk with age because of co-morbidities, immobility and pharmacotherapy. We aimed to…”
Get full text

Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin by Schwarz, T, Schmidt, B, Beyer, J, Schellong, S M

“…There are no data from prospective studies concerning the treatment of isolated calf muscle vein thrombosis (soleal and gastrocnemial muscle veins), found in…”
Get full text

Bridging anticoagulation for patients on long‐term vitamin‐K‐antagonists. A prospective 1 year registry of 311 episodes by HALBRITTER, K. M., WAWER, A., BEYER, J., OETTLER, W., SCHELLONG, S. M.

Get full text

Digital necrosis in a patient with atherosclerosis: also a paraneoplasia? by Stelzner, C, Zimmermann, F, Schellong, S M

“…A 59-year-old man was admitted with an acral necrosis of the left 3rd finger, which had developed during several weeks. Furthermore, the patient complained of…”
Get more information